Cancer Hospitals Fail to Reveal Prices: 'Not Always Shopable

Cancer Hospitals Fail to Reveal Prices: 'Not Always Shopable'

The Community Oncology Alliance was among the groups that did their own research in support of a plan to boost the federal penalties for hospitals that fail to meet standards for revealing prices.

Related Keywords

Miami , Florida , United States , New York , Tampa , Fox Chase Cancer Center , Pennsylvania , Texas , Dana Farber Cancer Institute , Massachusetts , Philadelphia , Memorial Hospital , Boston , Columbus , Ohio , Houston , University Of Miami Hospital , University Of Miami , Americans , Roswell Park , Aharon Ronny Gal , Ryan Merkow , Sloan Kettering , Moto Bioadvisors , H Lee Moffitt , Jim Jusko , Los Angeles , Arthurg James , Kenneth Norris Jr , National Cancer Institute , Md Anderson Cancer Center , American Oncologic Hospital Fox Chase Cancer Center , Community Oncology Alliance , Arthurg James Cancer Center , B Program , Firelight Health , Seattle Cancer Care Alliance , Expedia , Government Accountability Office , City Of Hope National Medical Center , Centers For Medicare Medicaid Services , University Of Texas Md Anderson Cancer Center , H Lee Moffitt Cancer Center , Turquoise Health , Roswell Park Memorial Institute , Alliance Of Dedicated Cancer Centers , Research Institute , Norris Comprehensive Cancer Center , Research Institute Hospital , Northwestern University , City Of Hope Comprehensive Cancer Center , Medicaid Services , Patient Rights Advocate , Dedicated Cancer Centers , Memorial Sloan Kettering , New York City , Medical News , Hope National Medical Center , Cancer Hospital , Miami Hospital , Lee Moffitt Cancer , Farber Cancer Institute , Allied Disease , Park Memorial Institute , Oncologic Hospital , Cancer Center , Hutchinson Cancer Research Center , Medscape Medical News , Hope Comprehensive Cancer , Comprehensive Cancer , Moffitt Cancer Center , Seattle Cancer Care , Patient Rights , Affordable Care Act , Health Care Reform , Inpatient Care , Hospitals , Cancer , Alignant Neoplasia , Arcinoma , Medicare , Insurance , Practice Management , Antineoplastic Drug , Nti Cancer Agents , Evacizumab , Rlotinib , Efitinib , Matinib , Ituximab , U11248 , Unitinib , Rastuzumab , Medicaid , Surgery , Biosimilars , Biosimilar Drugs , Follow On Biologics , Coronavirus , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Human ,

© 2025 Vimarsana